Hi S....... good point however if the Doctors present the report to the BoD the latter must be announce immediately.
But as you say 'strategically' (?) one never should underestimate what can be achieved ?
I am hoping the report is a good one. I see no reason why not. Would also like to know if the patients were ones (some) that would possibly not be accepted -due to their condition- in any normal trial (with due respect using 'normal'). In my opinion this would be a great outcome for some patients who would be excluded from normal trials.
AVR Price at posting:
$28.16 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)